Discover 3,132 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,132
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Houston TX, Franklin TN, Iowa City IA, Chicago IL,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT07109219
Phase 1, Phase 2, Recruiting
A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
for
Haematologic Neoplasms
Location: Houston TX, Tampa FL
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07064122
Phase 1, Recruiting
Augmenting Upper Limb Function and Functional Neuroplasticity Using Epidural Stimulation of the Cervical Spinal Cord
Get alerts for new trials in your area by subscribing now
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
for
Type 2 Diabetes Mellitus
Location: Houston TX, Sugar Land TX, Lake City FL, Leesburg FL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07662213
Phase 3, Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
for
Coronary Arterial Disease (CAD),
Location: Houston TX, Humble TX, San Antonio TX, Dallas TX,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT06959524
Recruiting
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
for
Liver Fibrosis, Hepatic Cirrhosis
Location: Houston TX, Austin TX, Georgetown TX, San Antonio TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07610837
Phase 2, Recruiting
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
for
Acute Myeloid Leukemia, Leukemia
Location: Houston TX, Easton PA, New York NY, Westbury NY
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06824168
Phase 2, Recruiting
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
for
Alzheimer Disease, Healthy
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute
Sex: All
Age: 18 - 70+
Code: NCT05582200
Recruiting
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Houston TX, Austin TX, Tyler TX, San Antonio TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06921785
Phase 3, Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
for
Aortic Regurgitation, Aortic Valve Insufficiency,
Location: Houston TX, Plano TX, Kansas City MO, St Louis MO,
Sponsor: JenaValve Technology, Inc.
Sex: All
Age: 0+
Code: NCT06608823
Recruiting
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
for
Multiple Myeloma
Location: Houston TX, Nashville TN, St Louis MO, Atlanta GA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07073547
Phase 1, Recruiting
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
for
Systemic Lupus Erythematosus
Location: Houston TX, New Orleans LA, El Paso TX, Cincinnati OH,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 17
Code: NCT05835310
Phase 3, Recruiting
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
for
Melanoma, Non-small Cell Lung Cancer,
Location: Houston TX, San Antonio TX, St Louis MO,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07115043
Phase 1, Phase 2, Recruiting
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Houston TX, San Antonio TX, Springfield MO,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06380751
Phase 3, Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation